Neogenomics Inc (NASDAQ:NEO) price on Wednesday, May 21, fall -7.38% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $7.40.
A look at the stock’s price movement, the close in the last trading session was $7.99, moving within a range at $7.375 and $7.87. The beta value (5-Year monthly) was 1.601. Turning to its 52-week performance, $19.11 and $6.08 were the 52-week high and 52-week low respectively. Overall, NEO moved -24.10% over the past month.
Neogenomics Inc’s market cap currently stands at around $952.34 million, with investors looking forward to this quarter’s earnings report slated for on 2025-Apr-28.
Turning to the stock’s technical picture we see that short term indicators suggest on average that NEO is a 100% Sell. On the other hand, the stock is on average a 100% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
8 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 1 analyst(s) rate the stock as a Hold, 7 recommend NEO as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
NEO’s current price about -8.76% and -17.28% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 38.52, while 7-day volatility ratio is 5.32% and 8.81% in the 30-day chart. Further, Neogenomics Inc (NEO) has a beta value of 1.69, and an average true range (ATR) of 0.60. Analysts have given the company’s stock an average 52-week price target of $15, forecast between a low of $12 and high of $18. Looking at the price targets, the low is -62.16% off current price level while to achieve the yearly target high, price needs to move -143.24%. Nonetheless, investors will most likely welcome a -102.7% jump to $15 which is the analysts’ median price.
If we refocus on Neogenomics Inc (NASDAQ:NEO), historical trading data shows that trading volumes averaged 1.57 over the past 10 days and 2.09 million over the past 3 months. The company’s latest data on shares outstanding shows there are 128.36 million shares.
The 1.30% of Neogenomics Inc’s shares are in the hands of company insiders while institutional holders own 99.91% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 4.75 million on 2025-04-30, giving us a short ratio of 1.78. The data shows that as of 2025-04-30 short interest in Neogenomics Inc (NEO) stood at 509.99999999999994 of shares outstanding, with shares short falling to 4.84 million registered in 2025-03-31. Current price change has pushed the stock -55.10% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the NEO stock continues to rise going into the next quarter.
